Table 4.
Diagnosis & Assessment Method |
Point Prevalence: Sample (N), % |
Point Prevalence: Males (N), % |
Point Prevalence: Females (N), % |
Lifetime Prevalence: Sample (N), % |
Lifetime Prevalence: Males (N), % |
Lifetime Prevalence: Females (N), % |
---|---|---|---|---|---|---|
PTSD CAPS (N=318) Subset followed up |
(60), 18.8% | (20), 16.4% | (37), 20.4% | (146),46.2% | (56), 45.5% | (85),47.8% |
MDD SCID (N=312) Subset followed up |
(51), 16.3% | (18), 13.8% | (30), 18.0% | (122),36.7% | (46), 32.6% | (70), 39.8% |